Showing results (161-170 of 185) with videos related to
Sort By:
Pageof 19
Science (New York, N.Y.)|January 30, 1970
Organic compounds in lunar samples: pyrolysis products, hydrocarbons, amino acidsB Nagy, D M Drew, P B Hamilton, et al.Health Services Research|September 21, 2010
Chronic care improvement in primary care: evaluation of an integrated pay-for-performance and practice-based care coordination program among elderly patients with diabetesPeter J Fagan, Alyson B Schuster, Cynthia Boyd, et al.International Clinical Psychopharmacology|January 1, 1990
Pharmacokinetics of lithium in patients treated with controlled release lithium formulationsJ D Phillips, D H Myers, J R King, et al.Microbiology and Immunology|July 11, 2000
Detection of hantaviral antibodies among patients with hepatitis of unknown etiology in JapanH Kariwa, K Yoshimatsu, K Araki, et al.The American Journal of Cardiology|March 4, 2021
Relation of Institutional Mitral Valve Surgical Volume to Surgical and Transcatheter Outcomes in Medicare PatientsColin M Barker, Matthew R Reynolds, Michael J Reardon, et al.Protein Science : a Publication of the Protein Society|March 30, 2000
Crystal structures of two mutants (K206Q, H207E) of the N-lobe of human transferrin with increased affinity for ironA H Yang, R T MacGillivray, J Chen, et al.Diabetes Care|June 6, 1998
Impact of a diabetes electronic management system on the care of patients seen in a subspecialty diabetes clinicS A Smith, M E Murphy, T R Huschka, et al.Medical Care|May 22, 2018
Going Beyond Clinical Care to Reduce Health Care Spending: Findings From the J-CHiP Community-based Population Health Management Program EvaluationShannon M E Murphy, Douglas E Hough, Martha L Sylvia, et al.Biochemistry|February 25, 1999
X-ray crystallography and mass spectroscopy reveal that the N-lobe of human transferrin expressed in Pichia pastoris is folded correctly but is glycosylated on serine-32M C Bewley, B M Tam, J Grewal, et al.Science (New York, N.Y.)|March 10, 1989
Structure of recombinant human renin, a target for cardiovascular-active drugs, at 2.5 A resolutionA R Sielecki, K Hayakawa, M Fujinaga, et al.Pageof 19